Synthesis of lavr-289
Ended Awarded Last action
- Contract number
- 75N93022F00009
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $198,565
Award facts
- Contract value 100% obligated
- $198,565.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $198,565 |
About this award
This $198,565 firm fixed-price delivery order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Sri International, a non-profit research institute, for the synthesis of LAVR-289. The contract is part of the NIH's larger "Nonclinical Services for Development of Interventional Agents" indefinite delivery, indefinite quantity (IDIQ) contract vehicle. Sri International has a history of providing research, engineering, and technical services to federal agencies including the Department of Health and Human Services, Department of Defense, and NASA through various prime and subcontracts. The work will be performed in West Menlo Park, California and is scheduled for completion by September 14, 2023. No small business or socioeconomic set-aside was used for this award.
Quick answers
Who was awarded contract 75N93022F00009?
75N93022F00009 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 15, 2022.
How much is contract 75N93022F00009 worth?
The government has obligated $198,565 on 75N93022F00009.
Is contract 75N93022F00009 an order under another contract?
Yes. 75N93022F00009 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93022F00009 competed?
The extent of competition for 75N93022F00009 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award